by Portfolio Grader | November 12, 2012 8:00 am
The ratings of three Medical Devices stocks are down this week, according to the Portfolio Grader[1] database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
ZELTIQ Aesthetics Inc. (NASDAQ:ZLTQ[2]) earns a F (“strong sell”) this week, moving down from last week’s grade of D (“sell”). In Portfolio Grader’s specific subcategories of Equity and Cash Flow, ZLTQ also gets F’s. The stock price has fallen 24.5% over the past month, worse than the 4.8% decrease the Nasdaq has seen over the same period of time. To get an in-depth look at ZLTQ, get Portfolio Grader’s complete analysis of ZLTQ stock[3].
This week, RTI Biologics (NASDAQ:RTIX[4]) falls to a D (“sell”), worse than last week’s grade of C (“hold”). RTI Biologics processes human and animal musculoskeletal tissues in producing allograft and xenograft implants. The stock price has fallen 6% over the past month. The stock currently has a trailing PE Ratio of 27.90. For a full analysis of RTIX stock, visit Portfolio Grader[5].
The rating of Staar Surgical (NASDAQ:STAA[6]) declines this week from a D to a F. Staar Surgical develops, manufactures, and markets high margin visual implants that improve a patient’s quality of vision. The stock also gets an F in Earnings Growth. Share prices fell 24% over the past month. The stock’s trailing PE Ratio is 521.00. For more information, get Portfolio Grader’s complete analysis of STAA stock[7].
Louis Navellier’s proprietary Portfolio Grader[8] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[9].
Source URL: https://investorplace.com/2012/11/3-medical-devices-stocks-to-sell-now-zltq-rtix-staa-2/
Copyright ©2024 InvestorPlace unless otherwise noted.